2023 - Research.com Best Female Scientist Award
2022 - Research.com Best Female Scientist Award
2019 - Fellow of the American Association for the Advancement of Science (AAAS)
Kornelia Polyak spends much of her time researching Cancer research, Cancer, Cell biology, Genetics and Breast cancer. Her Cancer research research includes themes of Cell, DNA methylation, Immunology, Colorectal cancer and Myoepithelial cell. Her biological study spans a wide range of topics, including Cancer cell, Stem cell and Cell type.
The concepts of her Cancer study are interwoven with issues in Phenotype and Epigenesis. Her Cell biology research focuses on Cyclin-dependent kinase and how it relates to Cyclin. In her work, Cell adhesion is strongly intertwined with Carcinoma, which is a subfield of Breast cancer.
Her primary areas of study are Cancer research, Breast cancer, Cancer, Internal medicine and Oncology. Her Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Cell, Epigenetics and Immunology. Her research in Carcinogenesis focuses on subjects like Cell biology, which are connected to Cyclin-dependent kinase complex, Apoptosis and Cell cycle.
Kornelia Polyak has researched Breast cancer in several fields, including Genetic heterogeneity and Disease, Pathology. Cancer is a subfield of Genetics that Kornelia Polyak studies. Her Cancer cell research includes themes of Cancer stem cell and CD44.
The scientist’s investigation covers issues in Breast cancer, Cancer research, Cancer, Internal medicine and Oncology. Her study looks at the intersection of Breast cancer and topics like Pathology with Carcinogenesis. Her research in Cancer research intersects with topics in Cancer cell, Triple-negative breast cancer, Bromodomain and Immune system.
Kornelia Polyak has included themes like Stromal cell and Personalized medicine in her Cancer study. Her study in the field of Estrogen receptor also crosses realms of Ruxolitinib. Her study in Cell biology is interdisciplinary in nature, drawing from both Cyclin-dependent kinase and Cellular differentiation.
Kornelia Polyak mainly focuses on Cancer, Breast cancer, Internal medicine, Oncology and Cancer research. Kornelia Polyak combines subjects such as Evolvability, Personalized medicine and Molecular evolution with her study of Cancer. Her Breast cancer study frequently links to adjacent areas such as Cancer cell.
Kornelia Polyak has researched Cancer research in several fields, including Epigenetics, Bromodomain, BRD4, Transcription factor and Immunology. Her Immunology study incorporates themes from Ductal carcinoma and Tumor progression. Kornelia Polyak works on Cell biology which deals in particular with Cancer stem cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani;Wenjun Guo;Mai Jing Liao;Elinor Ng Eaton.
Cell (2008)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak;Robert A. Weinberg.
Nature Reviews Cancer (2009)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub;Ajeeta B. Dash;Annie P. Vo;Andrew Sullivan.
Nature (2007)
A model for p53-induced apoptosis
Kornelia Polyak;Kornelia Polyak;Yong Xia;Jay L. Zweier;Kenneth W. Kinzler.
Nature (1997)
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
Kornelia Polyak;Mong Hong Lee;Hediye Erdjument-Bromage;Andrew Koff.
Cell (1994)
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
Kornelia Polyak;Jun-ya Kato;Mark J. Solomon;Charles J. Sherr.
Genes & Development (1994)
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
James G. Herman;Asad Umar;Kornelia Polyak;Jeremy R. Graff.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk;Vanessa Almendro;Vanessa Almendro;Kornelia Polyak.
Nature Reviews Cancer (2012)
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Philip D. Jeffrey;Alicia A. Russo;Kornelia Polyak;Emma Gibbs.
Nature (1995)
A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27Kip1-Deficient Mice
Matthew L. Fero;Michael Rivkin;Michael Tasch;Peggy Porter.
Cell (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Harvard University
Johns Hopkins University
Harvard University
Johns Hopkins University School of Medicine
Harvard University
Harvard University
Harvard University
Harvard University
Brigham and Women's Hospital
York University
University of Granada
University of Tokyo
Xi'an Jiaotong University
Czech Academy of Sciences
University of Wisconsin–Madison
University of Arkansas at Fayetteville
University of California, Santa Barbara
University of Alaska Fairbanks
Albert Einstein College of Medicine
Osaka University
Kyoto University
Chinese Academy of Sciences
Rutgers, The State University of New Jersey
University of Notre Dame
Stanford University